A RANDOMIZED TRIAL COMPARING EPTIFIBATIDE AND PLACEBO IN PATIENTS WITH DIFFUSE CORONARY DISEASE UNDERGOING DRUG-ELUTING STENTING.

Trial Profile

A RANDOMIZED TRIAL COMPARING EPTIFIBATIDE AND PLACEBO IN PATIENTS WITH DIFFUSE CORONARY DISEASE UNDERGOING DRUG-ELUTING STENTING.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2012

At a glance

  • Drugs Eptifibatide (Primary) ; Heparin
  • Indications Coronary artery disease; Myocardial ischaemia; Stent thrombosis
  • Focus Therapeutic Use
  • Acronyms INSTANT
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Jun 2012 European Clinical Trials Database record Actual Initiation Date is 23 Jan 2008.
    • 18 Oct 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top